SEC Filing Summary: Safety Shot, Inc. (SHOT)
Business Context and Reporting Period
This Form 8-K was filed by Safety Shot, Inc. (the "Company") on April 4, 2025, reporting events occurring on April 1, 2025. The Company is an emerging growth company incorporated in Delaware, with its principal executive offices in Jupiter, Florida. The filing details an amendment to a previously reported settlement agreement with Bigger Capital LLC regarding outstanding debt and litigation resolution.
Key Financial Metrics and Debt Obligations
The filing does not provide revenue, profit, cash flow, or margin data. It focuses on specific debt instruments and settlement terms:
- Convertible Bigger Note: Principal amount of $3.5 million, maturing June 30, 2025.
- Secured Convertible Bigger Note: Principal amount of $1.75 million, maturing December 31, 2026.
- Exchange Warrants: Warrants to purchase 5,332,889 shares of common stock at an exercise price of $0.4348 per share.
- Future Obligations: Potential issuance of a $2 million SAFE or a $4.5 million convertible note (9% interest, maturing December 31, 2027) if an Alternative Payment Method is utilized.
Material Changes and Agreement Terms
On April 1, 2025, the Company entered into an Amendment to the Settlement Agreement and Mutual Release with Bigger Capital, effective retroactively to January 20, 2025. Key terms include:
- Payment of Proceeds: In exchange for Bigger Capital agreeing not to convert the $3.5 million Convertible Bigger Note prior to July 21, 2025, the Company must pay Bigger Capital 10% of gross proceeds from any capital raise ("Financing").
- Application of Funds:
- Pre-maturity Financing: Proceeds are applied to pay down the $1.75 million Secured Convertible Bigger Note.
- Post-maturity Financing: Proceeds are first applied to the $2 million SAFE or $4.5 million convertible note (if applicable), and second to the Secured Convertible Bigger Note.
- Registration Statement Extension: Subject to the Company consummating a pre-maturity Financing by April 18, 2025, the deadline for the effectiveness of the Registration Statement is extended from April 5, 2025, to May 2, 2025.
- Warrant Price Adjustment: If the effective price per share in any Financing is less than the current exercise price of $0.4348, the exercise price of the Exchange Warrants will be reduced to the Base Share Price.
Outlook, Risks, and Contingencies
The filing highlights significant liquidity and financing contingencies:
- Financing Deadline: The extension of the Registration Statement effectiveness is contingent upon the Company completing a financing event by April 18, 2025.
- Dilution Risk: Future financings at prices below $0.4348 will trigger a reduction in the exercise price of existing warrants, potentially increasing dilution.
- Cash Flow Impact: The Company is obligated to remit 10% of gross proceeds from future capital raises to Bigger Capital within two business days of receipt, prioritizing debt repayment over other uses of capital.
Investor Verification Checklist
- Verify whether the Company has consummated a "pre-maturity Financing" by the April 18, 2025 deadline to secure the registration statement extension.
- Monitor the status of the $3.5 million Convertible Bigger Note maturing June 30, 2025, and the risk of conversion if financing targets are not met.
- Review the terms of the "Alternative Payment Method" referenced in the filing to understand the conditions under which the $4.5 million note or $2 million SAFE would be issued.
- Assess the impact of the 10% proceeds sweep on the Company's ability to fund operations from future capital raises.